We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guselkumab Beats Humira as Three Psoriasis Drugs Complete Phase III
Guselkumab Beats Humira as Three Psoriasis Drugs Complete Phase III
Three pharmaceutical companies announced Phase III trial results from their injectable psoriasis treatments — with one delivering better head-to-head clinical results than international top-selling drug Humira, which reached over $14 billion in sales in 2015.